[{"address1": "1 Enterprise Drive", "address2": "Suite 430", "city": "Shelton", "state": "CT", "zip": "06484-4779", "country": "United States", "phone": "203 221 7381", "fax": "203 557 3023", "website": "https://www.intensitytherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Lewis H. Bender M.A., M.B.A., M.S.", "age": 65, "title": "Founder, President, CEO & Chairman of the Board", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 597007, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph  Talamo CPA, M.B.A.", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 416930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Wesolowski CPA, M.B.A.", "age": 64, "title": "Principal Accounting Officer & Controller", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 260898, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James M. Ahlers", "age": 60, "title": "Executive Vice President of Corporate Finance", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 75088, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.4781, "open": 0.465, "dayLow": 0.4301, "dayHigh": 0.465, "regularMarketPreviousClose": 0.4781, "regularMarketOpen": 0.465, "regularMarketDayLow": 0.4301, "regularMarketDayHigh": 0.465, "payoutRatio": 0.0, "beta": 4.058, "forwardPE": -0.37118647, "volume": 2088146, "regularMarketVolume": 2088146, "averageVolume": 31038219, "averageVolume10days": 29713550, "averageDailyVolume10Day": 29713550, "bid": 0.43, "ask": 0.45, "bidSize": 1, "askSize": 1, "marketCap": 28684314, "fiftyTwoWeekLow": 0.185, "fiftyTwoWeekHigh": 3.176, "allTimeHigh": 11.44, "allTimeLow": 0.185, "fiftyDayAverage": 0.33418, "twoHundredDayAverage": 0.866375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 19359454, "profitMargins": 0.0, "floatShares": 52430107, "sharesOutstanding": 60064965, "sharesShort": 16769283, "sharesShortPriorMonth": 865945, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.3049, "heldPercentInsiders": 0.10381, "heldPercentInstitutions": 0.07052, "shortRatio": 0.59, "shortPercentOfFloat": 0.3171, "impliedSharesOutstanding": 65489304, "bookValue": 0.147, "priceToBook": 2.9795918, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -11736000, "trailingEps": -0.55, "forwardEps": -1.18, "52WeekChange": -0.8477707, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 0.438, "targetHighPrice": 5.0, "targetLowPrice": 1.5, "targetMeanPrice": 2.91667, "targetMedianPrice": 3.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 7067000, "totalCashPerShare": 0.118, "totalDebt": 118000, "quickRatio": 3.105, "currentRatio": 3.597, "debtToEquity": 1.634, "returnOnAssets": -1.01661, "returnOnEquity": -2.34697, "freeCashflow": -5259875, "operatingCashflow": -9500000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "INTS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1763168367, "regularMarketTime": 1763154000, "exchange": "NCM", "messageBoardId": "finmb_225412349", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Intensity Therapeutics, Inc.", "longName": "Intensity Therapeutics, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": -8.38737, "regularMarketPrice": 0.438, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1688131800000, "postMarketChangePercent": -1.8036529, "postMarketPrice": 0.4301, "postMarketChange": -0.0079, "regularMarketChange": -0.0401, "regularMarketDayRange": "0.4301 - 0.465", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 31038219, "fiftyTwoWeekLowChange": 0.253, "fiftyTwoWeekLowChangePercent": 1.3675675, "fiftyTwoWeekRange": "0.185 - 3.176", "fiftyTwoWeekHighChange": -2.7380002, "fiftyTwoWeekHighChangePercent": -0.8620907, "fiftyTwoWeekChangePercent": -84.77707, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754596800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.55, "epsForward": -1.18, "epsCurrentYear": -0.34333, "priceEpsCurrentYear": -1.2757405, "fiftyDayAverageChange": 0.103819996, "fiftyDayAverageChangePercent": 0.31067088, "twoHundredDayAverageChange": -0.42837504, "twoHundredDayAverageChangePercent": -0.49444526, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-06-30", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "Intensity Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]